• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply
Sort by Relevance
CSV RIS
Search Results [15895 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2015 HAYES, Inc. Impella 5.0 (Abiomed Inc.) for emergent hemodynamic support in patients with cardiogenic shock
2015 HAYES, Inc. Nucleus hybrid L24 cochlear implant system (Cochlear Limited) for hearing loss
2015 HAYES, Inc. Pulsed Electromagnetic Field (PEMF) therapy for treatment of postoperative knee pain and edema
2015 HAYES, Inc. Tandem autologous stem cell transplant for Hodgkin lymphoma
2015 NIHR Health Technology Assessment programme Evaluation and validation of social and psychological markers in randomised trials of complex interventions in mental health: a methodological research programme
2015 Institute for Clinical Effectiveness and Health Policy (IECS) [Percutaneous Mitral Valve Repair System (MitraClip®) for mitral valve insufficiency]
2015 Institute for Clinical Effectiveness and Health Policy (IECS) [Deep brain stimulation for Parkinson's disease]
2015 Institute for Clinical Effectiveness and Health Policy (IECS) [Intracorneal rings for patients with keratoconus]
2015 Institute for Clinical Effectiveness and Health Policy (IECS) [Ki-67 proliferative index in patients with early breast cancer]
2015 Institute for Clinical Effectiveness and Health Policy (IECS) [Teduglutide for the treatment of patients with short bowel syndrome]
2015 Institute for Clinical Effectiveness and Health Policy (IECS) [Deep brain stimulation in patients with treatment-resistant depressive disorder, obsessive compulsive disorder and Tourette syndrome]
2015 Institute for Clinical Effectiveness and Health Policy (IECS) [Genomic expression tests in patients with breast cancer: MammaPrint®, Oncotype DX® and Prosigna®]
2015 Institute for Clinical Effectiveness and Health Policy (IECS) [Insulin infusion pumps for diabetic patients]
2015 Institute for Clinical Effectiveness and Health Policy (IECS) [Belimumab for the treatment of Systemic Lupus Erythematosus]
2015 Institute for Clinical Effectiveness and Health Policy (IECS) [Denosumab for the treatment of solid tumor bone metástasis]
2015 Institute for Clinical Effectiveness and Health Policy (IECS) [Fractional flow reserve in coronary artery]
2015 Institute for Clinical Effectiveness and Health Policy (IECS) [Porcine biological prosthesis for the management of anal fistula]
2015 Institute for Clinical Effectiveness and Health Policy (IECS) [Corneal collagen crosslinking with riboflavin for keratoconus patients]
2015 Institute for Clinical Effectiveness and Health Policy (IECS) [Sofosbuvir and simeprevir-based schemes for the management of hepatitis C]
2015 Institute for Clinical Effectiveness and Health Policy (IECS) [Raltegravir for the treatment of human immunodeficiency virus infection]
2015 Institute for Clinical Effectiveness and Health Policy (IECS) [Ombitasvir, paritaprevir and ritonavir regimens in hepatitis C patients]
2015 Institute for Clinical Effectiveness and Health Policy (IECS) [Ceritinib for the treatment of ALK-positive metastatic non-small cell lung cancer]
2015 Institute for Clinical Effectiveness and Health Policy (IECS) [Vitamin D screening in adults]
2015 Institute for Clinical Effectiveness and Health Policy (IECS) [Cabazitaxel, abiraterone and enzalutamide in metastatic castration-resistant prostate cancer not responding to docetaxel]
2015 Institute for Clinical Effectiveness and Health Policy (IECS) [Tecar therapy for the management of osteoarticular lesions]
2015 Institute for Clinical Effectiveness and Health Policy (IECS) [Dynamic magnetic resonance imaging for focal liver lesion assessment]
2015 Institute for Clinical Effectiveness and Health Policy (IECS) [Intra-articular hyaluronic acid (viscosupplementation) in osteoarthritis]
2015 Institute for Clinical Effectiveness and Health Policy (IECS) [Cognitive rehabilitation in cognitive deficit secondary to stroke]
2015 Institute for Clinical Effectiveness and Health Policy (IECS) [Omalizumab for the management of asthma]
2015 Institute for Clinical Effectiveness and Health Policy (IECS) [Usefulness of the ALCAT test in food intolerance]
2015 NIHR Health Technology Assessment programme Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysis
2015 NIHR Public Health Research (PHR) programme Sexual health promotion for young people delivered via digital media: a scoping review
2015 NIHR Public Health Research (PHR) programme A cluster randomised controlled trial comparing the effectiveness and cost-effectiveness of a school-based cognitive behavioural therapy programme (FRIENDS) in the reduction of anxiety and improvement in mood in children aged 9/10 years
2015 University of York Enhancing access in primary care settings
2015 Institute for Clinical Evaluative Sciences (ICES) Brain disorders in Ontario: prevalence, incidence and costs from health administrative data
2015 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Insulin degludec/liraglutide (Xultophy®)
2015 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Fosfomycin (Fomicyt®)
2015 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Travoprost (Travatan®)
2015 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Midodrine hydrochloride (Bramox®)
2015 Adelaide Health Technology Assessment (AHTA) Life saving drugs programme review: technical assessment
2015 Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) [Bioquell airborne disinfection system]
2015 Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) [Pre-hospital ECMO for refractory cardiac arrest]
2015 Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) [Fully bioresorbable drug-eluting coronary scaffolds: A review]
2015 Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) [Radical-7™ – non-invasive continuous monitoring of hemoglobin]
2015 Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) [STAR™ – radiofrequency ablation system for vertebral metastasis]
2015 Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) [Aquapheresis – ultrafiltartion for congestive heart failure]
2015 Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) [Antigermix – disinfection of endocavitary ultrasonography probes]
2015 Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) [Vivostat® fibrin sealant]
2015 Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) [Magnetic growth rods for the scoliosis treatment in children]
2015 Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) [SpotOn™ device for temperature monitoring]
2015 Health Quality Ontario (HQO) Pancreas islet transplantation for patients with type 1 diabetes mellitus: a clinical evidence review
2015 Health Quality Ontario (HQO) Pancreas islet transplantation for patients with type 1 diabetes mellitus: OHTAC recommendation
2015 Health Quality Ontario (HQO) Patient perspectives on quality of life with controlled type 1 diabetes mellitus: a systematic review and qualitative meta-synthesis
2015 Health Quality Ontario (HQO) Transient elastography for assessment of liver fibrosis and steatosis: an evidence-based analysis
2015 Health Quality Ontario (HQO) Transient elastography for assessment of liver fibrosis and steatosis: OHTAC recommendation
2015 Health Quality Ontario (HQO) Transient elastography and controlled attenuation parameter for diagnosing liver fibrosis and steatosis in Ontario: an economic analysis
2015 Institut national d'excellence en sante et en services sociaux (INESSS) [Gene sequencing of tumours: clinical validity and utility of molecular profiles obtained by next-generation sequencing (NGS) technologies]
2015 NIHR Health Technology Assessment programme Behaviour change techniques: the development and evaluation of a taxonomic method for reporting and describing behaviour change interventions (a suite of five studies involving consensus methods, randomised controlled trials and analysis of qualitative data)
2015 NIHR Public Health Research (PHR) programme Preventing alcohol misuse in young people: an exploratory cluster randomised controlled trial of the Kids, Adults Together (KAT) programme
2015 NIHR Health Services and Delivery Research programme What evidence is there on the effectiveness of different models of delivering urgent care? A rapid review
2015 NIHR Health Services and Delivery Research programme Collective action for knowledge mobilisation: a realist evaluation of the Collaborations for Leadership in Applied Health Research and Care
2015 Agency for Healthcare Research and Quality (AHRQ) Management and outcomes of binge-eating disorder
2015 Agency for Healthcare Research and Quality (AHRQ) Nonpharmacological versus pharmacological treatments for adult patients with major depressive disorder
2015 NIHR Health Services and Delivery Research programme Family-Reported Experiences Evaluation (FREE) study: a mixed-methods study to evaluate families' satisfaction with adult critical care services in the NHS
2015 Health Information and Quality Authority (HIQA) Health technology assessment of a selective BCG vaccination programme
2015 Health Information and Quality Authority (HIQA) Health technology assessment (HTA) of a national screening programme for atrial fibrillation in primary care
2015 Health Information and Quality Authority (HIQA) Health technology assessment of the use of information technology for early warning and clinical handover systems
2015 Agency for Healthcare Research and Quality (AHRQ) Diagnosis of right lower quadrant pain and suspected acute appendicitis
2015 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Raltegravir (Isentress®)
2015 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Sucroferric oxyhydroxide (Velphoro®)
2015 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Tinzaparin sodium (Innohep®)
2015 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Denosumab (Xgeva®)
2015 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Tedizolid phosphate (Sivextro®)
2015 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Insulin glargine (Abasaglar®)
2015 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Insulin degludec/liraglutide (Xultophy®)
2015 Norwegian Knowledge Centre for the Health Services (NOKC) [First aid training may improve first aid skills]
2015 Norwegian Knowledge Centre for the Health Services (NOKC) A health technology assessment of the new drugs for inoperable or metastatic malignant melanoma patients
2015 NIHR Health Services and Delivery Research programme What is the evidence for the effectiveness, appropriateness and feasibility of group clinics for patients with chronic conditions?
2015 Institut national d'excellence en sante et en services sociaux (INESSS) [Detection and diagnosis of Alzheimer's disease and other neurocognitive disorders]
2015 Institut national d'excellence en sante et en services sociaux (INESSS) [Bendamustine for the treatment of follicular lymphoma]
2015 Agency for Healthcare Research and Quality (AHRQ) Management of insomnia disorder
2015 Agency for Healthcare Research and Quality (AHRQ) Health information exchange
2015 Agency for Healthcare Research and Quality (AHRQ) Systematic review for effectiveness of hyaluronic acid in the treatment of severe degenerative joint disease (DJD) of the knee
2015 Health Council of the Netherlands Gezondheidsraad (GR) Vaccination against pertussis: aims and strategy
2015 Health Council of the Netherlands Gezondheidsraad (GR) 4,4'-Methylenedianiline - Health-based calculated occupational cancer risk values
2015 Health Council of the Netherlands Gezondheidsraad (GR) 1,4-Dioxane - re-evaluation of the carcinogenicity and genotoxicity
2015 Health Council of the Netherlands Gezondheidsraad (GR) 2,6-Xylidine - re-evaluation of the carcinogenicity and genotoxicity
2015 Health Council of the Netherlands Gezondheidsraad (GR) Methodology for the evaluation of the evidence for the Dutch dietary guidelines 2015 - background document
2015 Health Council of the Netherlands Gezondheidsraad (GR) Shiftwork and health risks: possibilities for prevention
2015 HAYES, Inc. Absorbable perirectal spacer (SpaceOAR System; Augmenix Inc.) during radiation therapy for prostate cancer
2015 HAYES, Inc. Adalimumab (humira) for treatment of pediatric Crohn's disease
2015 HAYES, Inc. Augment bone graft (Wright Medical Group Inc.) for bone regeneration in ankle and/or hindfoot fusions
2015 HAYES, Inc. Eliglustat (Cerdelga) for Gaucher disease type 1
2015 HAYES, Inc. Elosulfase alpha (Vimizim) for treatment of Morquio A Syndrome
2015 HAYES, Inc. Flibanserin (Addyi) for premenopausal women with hypoactive sexual desire disorder
2015 HAYES, Inc. iFuse implant system (SI-BONE Inc.) for sacroiliac joint fusion for treatment of low back pain
2015 HAYES, Inc. Intravenous golimumab (Simponi Aria) for treatment of active rheumatoid arthritis
2015 HAYES, Inc. Laminotomy for lumbar spinal stenosis
2015 HAYES, Inc. Liraglutide (Saxenda) for weight loss in non-diabetic obese adults
2015 HAYES, Inc. Lumacaftor-ivacaftor (Orkambi) for treatment of cystic fibrosis